Cancer Research Institute CEO and Director of Scientific Affairs Jill O'Donnell-Tormey, PhD, invites cancer immunotherapy luminaries and CRI Scientific Advisory Council director and member, respectively, James P. Allison, PhD (2018 Nobel Prize Winner) of The University of Texas MD Anderson Cancer Center and E. John Wherry, PhD, DPhil, of the University of Pennsylvania, to discuss the future of cancer immunotherapy research and the power of data and data science to unlock next-generation cures for more cancers.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
